Ebola outbreak and investigational drug controversy


  • Krishnan Venadaragava Chary Department of Pharmacology, Saveetha Medical College, Chennai, Tamil Nadu


In 2014, first announcement on Ebola virus epidemic was made on 25 March by the World Health Organisation (WHO). Infection occurred in four southern regions of guinea, 86 people were infected and 69 people died of Ebola. This epidemic was caused by Zaire strain and infection was spreading rapidly, by March 31 2014 another 16 cases reported to the WHO.


Clarence J. Peters. Ebola and marbug viruses. In: Clarence J. Peters, eds. Harrison’s Principle of Internal Medicine. 17th ed. New York: McGraw-Hill; 2008: 1240-1242.

Joel G. Breman, Karl M. Johnson. Ebola then and now. N Engl J Med. 2014;371:1663-6.

WHO Ebola Response Team. Ebola virus disease in West Africa - the first 9 months of the epidemic and forward projections. N Engl J Med. 2014;371:1481-95.

Sylvain Baiz, Delphine Pannetier, Lisa Oestereich, Toni Rieger, Lamine Koivogui. Emergence of Zaire Ebola virus disease in guinea. N Engl J Med. 2014;371:1418-25.

Centre for Disease Control. Question and answers on Ebola, 2014. Available at: http://www.cdc.gov/vhf/ebola/outbreaks/guinea/qa.html. Accessed 9 August 2014.




How to Cite

Chary, K. V. (2017). Ebola outbreak and investigational drug controversy. International Journal of Research in Medical Sciences, 3(1), 381–382. Retrieved from https://www.msjonline.org/index.php/ijrms/article/view/1281



Letter to the Editor